• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Collegium Pharmaceutical

Anonymous board for Collegium Pharmaceutical
Replies
5
Views
3K
anonymous
Replies
6
Views
3K
anonymous
Replies
21
Views
6K
anonymous
Replies
67
Views
19K
anonymous
Replies
2
Views
2K
anonymous
Replies
53
Views
12K
anonymous
Replies
15
Views
7K
anonymous
Replies
1
Views
2K
anonymous
Replies
43
Views
16K
anonymous
Replies
6
Views
3K
anonymous
Replies
10
Views
3K
anonymous
Replies
14
Views
3K
anonymous
Replies
15
Views
5K
anonymous
Replies
1
Views
2K
anonymous
Replies
3
Views
2K
anonymous